Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
A physician should protect the best interest of the patient and the patient's family in the event that an end-of-life case gains media attention and the treating physician and nontreating physicians are asked to comment.